Skip to Main Content

Browse issues

The Journal of Infectious Diseases Cover Image for Volume 222, Issue 11
Volume 222, Issue 11
1 December 2020
ISSN 0022-1899
EISSN 1537-6613

Volume 222, Issue 11, 1 December 2020

EDITORIAL COMMENTARIES

James L Hadler
The Journal of Infectious Diseases, Volume 222, Issue 11, 1 December 2020, Pages 1759–1761, https://doi.org/10.1093/infdis/jiaa571
Charlene M Kahler
The Journal of Infectious Diseases, Volume 222, Issue 11, 1 December 2020, Pages 1762–1763, https://doi.org/10.1093/infdis/jiaa079
Benjamin A Lopman and Julia M Baker
The Journal of Infectious Diseases, Volume 222, Issue 11, 1 December 2020, Pages 1764–1767, https://doi.org/10.1093/infdis/jiaa033

PERSPECTIVE

Robert W Eisinger and others
The Journal of Infectious Diseases, Volume 222, Issue 11, 1 December 2020, Pages 1768–1771, https://doi.org/10.1093/infdis/jiaa051

COVID PERSPECTIVE

Saki Takahashi and others
The Journal of Infectious Diseases, Volume 222, Issue 11, 1 December 2020, Pages 1772–1775, https://doi.org/10.1093/infdis/jiaa523
Richard K Zimmerman and others
The Journal of Infectious Diseases, Volume 222, Issue 11, 1 December 2020, Pages 1776–1779, https://doi.org/10.1093/infdis/jiaa569

Allocation of the initial doses of coronavirus disease 2019 vaccines should account for epidemiology, vaccinology, bioethics, and racial disparities. Our priority tiers for vaccination are critical infrastructure, those at highest medical benefit, and those chosen by a weighted Area-Deprivation Index lottery.

MAJOR ARTICLES AND BRIEF REPORTS

COVID-19

Hao Lei and others
The Journal of Infectious Diseases, Volume 222, Issue 11, 1 December 2020, Pages 1780–1783, https://doi.org/10.1093/infdis/jiaa570
You Zou and others
The Journal of Infectious Diseases, Volume 222, Issue 11, 1 December 2020, Pages 1784–1788, https://doi.org/10.1093/infdis/jiaa301
Christophe Guervilly and others
The Journal of Infectious Diseases, Volume 222, Issue 11, 1 December 2020, Pages 1789–1793, https://doi.org/10.1093/infdis/jiaa528
Richard K Sterling and others
The Journal of Infectious Diseases, Volume 222, Issue 11, 1 December 2020, Pages 1794–1797, https://doi.org/10.1093/infdis/jiaa550

The FIB-4 Index, a simple tool developed to predict hepatic fibrosis, was found to independently be associated with need for mechanical ventilation and 30-day mortality in hospitalized patients with COVID-19.

Raquel A Binder and others
The Journal of Infectious Diseases, Volume 222, Issue 11, 1 December 2020, Pages 1798–1806, https://doi.org/10.1093/infdis/jiaa575

In studying 20 hospitalized COVID-19 patients, we found the highest prevalence of severe acute respiratory syndrome coronavirus 2 RNA among patients’ nasopharyngeal and saliva samples (high correlation), but also RNA on fomites and in room air. However, only 2 nasopharyngeal swabs were culture positive.

Laura Falasca and others
The Journal of Infectious Diseases, Volume 222, Issue 11, 1 December 2020, Pages 1807–1815, https://doi.org/10.1093/infdis/jiaa578

Autopsy findings in patients with COVID-19 showed deaths were due to cardiorespiratory failure, predominantly caused by acute lung injury, microvascular damage, and thrombosis. COVID-19 causes multisystem disease and significant pathology in most organs in patients with and without comorbidities.

BACTERIA

Odile B Harrison and others
The Journal of Infectious Diseases, Volume 222, Issue 11, 1 December 2020, Pages 1816–1825, https://doi.org/10.1093/infdis/jiaa002

Availability of gonococcal whole genome sequence data enhances our understanding of the population biology of this increasingly antimicrobial-resistant human pathogen. Here, genes core to the gonococcus are defined, which can be exploited to track emergence and transmission.

Ana Cehovin and others
The Journal of Infectious Diseases, Volume 222, Issue 11, 1 December 2020, Pages 1826–1836, https://doi.org/10.1093/infdis/jiaa003

Resistance plasmids are widespread in Neisseria gonorrhoeae in less wealthy countries. The presence and type of plasmid are closely associated with the core genome. Our results highlight how the cooperation between plasmids has important implications for the emergence of resistance.

HIV/AIDS

Nikolaus Jilg and others
The Journal of Infectious Diseases, Volume 222, Issue 11, 1 December 2020, Pages 1837–1842, https://doi.org/10.1093/infdis/jiaa294

In a large cohort of human immunodeficiency virus (HIV) controllers (AIDS Clinical Trials A5308), HIV-specific T-cell responses were higher in nonviremic than in viremic controllers. Despite decreasing T-cell responses on antiretroviral therapy, controller status was preserved after therapy was stopped.

Shane D Falcinelli and others
The Journal of Infectious Diseases, Volume 222, Issue 11, 1 December 2020, Pages 1843–1852, https://doi.org/10.1093/infdis/jiaa298

Cross-sectional analysis of age- and race-matched antiretroviral-suppressed HIV seropositive participants demonstrated no evident sex differences in the frequency of inducible replication-competent HIV or intact HIV DNA within resting CD4 T cells. Marginal sex differences in immune activation markers were observed.

KAWASAKI DISEASE

Daniel Quiat and others
The Journal of Infectious Diseases, Volume 222, Issue 11, 1 December 2020, Pages 1853–1857, https://doi.org/10.1093/infdis/jiaa253

High-throughput antibody profiling of acute sera from patients with Kawasaki disease demonstrates no evidence of a shared antibody response to known human viruses.

PATHOGENESIS AND HOST RESPONSE

Elizabeth T Rogawski McQuade and others
The Journal of Infectious Diseases, Volume 222, Issue 11, 1 December 2020, Pages 1858–1868, https://doi.org/10.1093/infdis/jiaa031

We estimated natural immunity to enteric pathogens as the effects of previous infections on the incidence of subsequent infections in children under 2. Prior rotavirus, Cryptosporidium, norovirus GII, astrovirus, and Shigella infections were associated with lower risk of subsequent diarrhea.

Eleonora Ciarlo and others
The Journal of Infectious Diseases, Volume 222, Issue 11, 1 December 2020, Pages 1869–1881, https://doi.org/10.1093/infdis/jiz692

We used preclinical models to demonstrate that trained immunity confers broad-spectrum protection against bacterial infections. Trained immunity increased myeloid progenitors and circulating inflammatory monocytes and neutrophils, and depletion or neutralization of monocytes/macrophages and interleukin 1 signaling impaired trained immunity-mediated protection.

Sarah M Beno and others
The Journal of Infectious Diseases, Volume 222, Issue 11, 1 December 2020, Pages 1882–1893, https://doi.org/10.1093/infdis/jiaa295

The authors demonstrate that Streptococcus pneumoniae kills cardiomyocytes during invasive disease in mice. Cardiac damage was necroptosis dependent and long lasting, possibly explaining adverse cardiac events in convalescent humans. Necroptosis inhibition protected against acute and long-term cardiac damage.

VIRUSES

Danielle P Porter and others
The Journal of Infectious Diseases, Volume 222, Issue 11, 1 December 2020, Pages 1894–1901, https://doi.org/10.1093/infdis/jiaa290

The small molecule remdesivir (GS-5734) showed therapeutic efficacy in a nonhuman primate model of Marburg disease with treatment initiation 5 days post inoculation, supporting further assessment of remdesivir for the treatment of Marburg virus disease in humans.

Chang Kyung Kang and others
The Journal of Infectious Diseases, Volume 222, Issue 11, 1 December 2020, Pages 1902–1909, https://doi.org/10.1093/infdis/jiaa291

Flow cytometric analyses revealed that patients with cancer receiving immune checkpoint inhibitors (ICIs) had higher influenza-specific vaccine-elicited cell-mediated immune responses compared with those receiving cytotoxic chemotherapy after seasonal influenza vaccination, which supports annual influenza vaccination in ICI-treated patients.

Sarah M Bartsch and others
The Journal of Infectious Diseases, Volume 222, Issue 11, 1 December 2020, Pages 1910–1919, https://doi.org/10.1093/infdis/jiaa292

We estimate that norovirus costs $10.6 billion annually, based on the latest US incidence estimate. Sporadic community cases represented >90% and productivity losses 89% of the total burden, with more than half the burden in adults aged ≥45 years.

Bethany Charlton and others
The Journal of Infectious Diseases, Volume 222, Issue 11, 1 December 2020, Pages 1920–1927, https://doi.org/10.1093/infdis/jiaa299

A high degree of correlation between standard MAPREC test and NGS measurements of 472C nucleotide content in Sabin 3 oral polio vaccines was observed demonstrating that NGS can be used for the batch release of such vaccines.

Rajshree Balaji and others
The Journal of Infectious Diseases, Volume 222, Issue 11, 1 December 2020, Pages 1928–1937, https://doi.org/10.1093/infdis/jiaa302

There is limited published evidence supporting higher female-to-male than male-to-female human papillomavirus transmission. There is significant heterogeneity among studies; however, future transmission investigations should consider factors such as age and recency of relationships as key variables.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close